| Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells … T Nakamura, T Nakanishi, T Haruta, Y Shirasaka, JP Keogh, I Tamai Molecular pharmaceutics 7 (1), 187-195, 2010 | 108 | 2010 |
| Functional characterization of ergothioneine transport by rat organic cation/carnitine transporter Octn1 (slc22a4) T Nakamura, K Yoshida, H Yabuuchi, T Maeda, I Tamai Biological and Pharmaceutical Bulletin 31 (8), 1580-1584, 2008 | 67 | 2008 |
| Involvement of choline transporter-like proteins, CTL1 and CTL2, in glucocorticoid-induced acceleration of phosphatidylcholine synthesis via increased choline uptake T Nakamura, R Fujiwara, N Ishiguro, M Oyabu, T Nakanishi, Y Shirasaka, ... Biological and Pharmaceutical Bulletin 33 (4), 691-696, 2010 | 50 | 2010 |
| Decreased proliferation and erythroid differentiation of K562 cells by siRNA-induced depression of OCTN1 (SLC22A4) transporter gene T Nakamura, S Sugiura, D Kobayashi, K Yoshida, H Yabuuchi, S Aizawa, ... Pharmaceutical research 24, 1628-1635, 2007 | 44 | 2007 |
| Modeling corticosteroid pharmacokinetics and pharmacodynamics, part II: sex differences in methylprednisolone pharmacokinetics and corticosterone suppression VS Ayyar, DC DuBois, T Nakamura, RR Almon, WJ Jusko Journal of Pharmacology and Experimental Therapeutics 370 (2), 327-336, 2019 | 23 | 2019 |
| Transport characteristics of L‐citrulline in renal apical membrane of proximal tubular cells K Mitsuoka, Y Shirasaka, A Fukushi, M Sato, T Nakamura, T Nakanishi, ... Biopharmaceutics & drug disposition 30 (3), 126-137, 2009 | 22 | 2009 |
| Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype‐Guided Dosing of Tamoxifen T Nakamura, K Toshimoto, W Lee, CK Imamura, Y Tanigawara, ... CPT: pharmacometrics & systems pharmacology 7 (7), 474-482, 2018 | 15 | 2018 |
| Population pharmacokinetics of 1.5 mg levonorgestrel in obesity: comparison of compartmental and minimal PBPK (mPBPK) models EAG Molins, T Nakamura, M Natavio, FZ Stanczyk, WJ Jusko JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 45, S27-S27, 2018 | 1 | 2018 |
| 機序に基づいた数理モデル解析~ 薬物動態学, そして薬力学~ 中村利通 薬剤学 81 (3), 236-241, 2021 | | 2021 |
| Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression (vol 370, pg 327 … VS Ayyar, DC DuBois, T Nakamura, RR Almon, WJ Jusko JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 370 (3), 436-436, 2019 | | 2019 |
| DRUG-INDUCED LUNG TOXICITY CAUSED BY INHIBITION OF CHOLINE AND PHOSPHATIDYLCHOLINE TRANSPORTERS IN ALVEOLAR TYPE II CELLS T Nakamura, Y Li, T Sato, N Ishiguro, Y Shirasaka, I Tamai DRUG METABOLISM REVIEWS 40, 219-220, 2008 | | 2008 |
| Expression and function of organic cation transporter OCTN1 in hematopoietic cells during erythroid differentiation T NAKAMURA, K YOSHIDA, D KOBAYASHI, S SUGIURA, T MAEDA, ... Yakugaku zasshi 126, 172-173, 2006 | | 2006 |
